Carregant...
Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
OBJECTIVE: To evaluate the cost-effectiveness of a genetic testing policy for HNF1A-, HNF4A-, and GCK-MODY in a hypothetical cohort of type 2 diabetic patients 25–40 years old with a MODY prevalence of 2%. RESEARCH DESIGN AND METHODS: We used a simulation model of type 2 diabetes complications based...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3867988/ https://ncbi.nlm.nih.gov/pubmed/24026547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0410 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|